The latest developments for enriching and analyzing antigen- and virus-specific T cells [WEBINAR]

128 Aufrufe

  • Danke für die Bewertung! Teile es mit Deinen Freunden!

    Danke für Deine Bewertung!

admin
Published
For more information, visit: https://www.miltenyibiotec.com/lp/assisting-researchers-in-their-work-addressing-viral-threats/solutions--for-stimulation-enrichment-and-analysis-of-rare-virus-specific-T-cells.html The COVID-19 pandemic has placed urgency on precise analysis of rare antigen- and virus-specific T cells. At Miltenyi Biotec, we offer a complete workflow for isolation, stimulation, sorting and analysis of antigen- and virus-specific T cells. Analysis of these rare cells is not only important to reveal whether or not long-term protection is gained after infection or vaccination, but also essential for understanding fundamental immunological processes in immuno-oncology and immune tolerance.

Working with antigen-specific T cells can prove challenging to researchers. Critically low cell frequencies, inflammatory environments, unspecific labeling and high background often hamper reliable analysis.
Our workflow has been optimized at every step to address key challenges faced by researchers working with these rare cells. The correct combination of products for sample preparation, cell stimulation, pre-enrichment and flow cytometry is key for a successful analysis.

We are confident that we can assist you, in even the most challenging research projects and your work on viral threats like COVID-19.

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging.Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec more than 3,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.
Kategorien
Corona Virus aktuelle Videos
Kommentare deaktiviert.

Als nächstes

Яндекс.Метрика Top.Mail.Ru